Life SciencesMergers, Acquisitions, and Partnerships


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This deliverable provides insights on the many macro issues facing the life sciences industry which have resulted in consolidation and an increasing number in partnerships. This research service presents merger and acquisition activity by select life sciences participants and business strategies for new drug development, including contract research organization (CRO) and open innovation partnerships.

Table of Contents

Life Sciences—Mergers, Acquisitions, and PartnershipsAnalysis of the Life Sciences IndustryExecutive SummaryLife Sciences M&A OverviewM&A Activity for Select Life Sciences PlayersBusiness Strategies for New Drug DevelopmentOpen Innovation Case StudiesConclusionsCertificationLegal DisclaimerThe Frost & Sullivan Story

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.